Aytu Biopharma (AYTU) Shares Outstanding (Weighted Average) (2010 - 2026)

Aytu Biopharma (AYTU) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $10.5 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $10.5 million, up 71.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.5 million (up 71.35% YoY), and the FY2025 annual result was $6.3 million, up 13.39% from the prior year.
• Shares Outstanding (Weighted Average) rose to $10.5 million in Q1 2026 per AYTU's latest filing, from $10.0 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $11.7 million in Q1 2022 and troughed at $15571.0 in Q2 2025.
• A 5-year average of $5.5 million and a median of $5.5 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Weighted Average) surged 1405.33% in 2023, then slumped 99.72% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $1.7 million in 2022, then soared by 223.77% to $5.5 million in 2023, then climbed by 7.27% to $5.9 million in 2024, then jumped by 70.11% to $10.0 million in 2025, then increased by 4.74% to $10.5 million in 2026.
• Business Quant data shows AYTU's Shares Outstanding (Weighted Average) at $10.5 million in Q1 2026, $10.0 million in Q4 2025, and $9.4 million in Q3 2025.